An aspirin-free strategy and optical coherence tomography observations after percutaneous coronary intervention: Insights from the STOPDAPT-3 trial.
Obayashi Y, Natsuaki M, Watanabe H, Morimoto T, Yamamoto K, Nishikawa R, Miyazawa A, Suzuki N, Suwa S, Kirigaya H, Wakabayashi K, Kawai K, Onishi Y, Morishima I, Okayama H, Uehara H, Hibi K, Ono K, Kimura T; STOPDAPT-3 Investigators.
Obayashi Y, et al. Among authors: uehara h.
J Cardiol. 2024 May 10:S0914-5087(24)00083-2. doi: 10.1016/j.jjcc.2024.05.002. Online ahead of print.
J Cardiol. 2024.
PMID: 38735384
No abstract available.